News for:

 

Click the Chemical Profile link above for detailed information. Visit Betterchem's Drug Index for… Exclusivity Patents and market exclusivity Drug Information Prescribing and other information DMFs Type 2 drug master files Databases Free access to database search 21 CFR FDA regulations for this drug Federal Register FR search results for this drug Drug Recalls For Rx's using this API

FDA Approval Activities for this Drug… Bupropion Hydrochloride Extended-Release Tablets, 100 and 150 mg, Eon Labs Manufacturing, ANDA 75-932 1/24/02 4/10/03 Bupropion Hydrochloride Tablets, 75 mg and 100 mg, Eon Labs Manufacturing, ANDA 75-613 10/10/00 11/7/00 12/5/01 Bupropion Hydrochloride Tablets, 75 mg and 100 mg, Invamed ANDA 75-584 2/7/00 2/11/00 6/7/01 Bupropion Hydrochloride Tablets, 75 mg and 100 mg, Mylan ANDA 75-491 Wellbutrin (bupropion hydrochloride) Immediate-Release & Sustained-Release Tablets, GlaxoSmithKline NDA 18-644/S-026 & 20-358/S-029 10/22/02 10/28/02 Wellbutrin (bupropion hydrochloride) Immediate-Release & Sustained-Release Tablets, 75 mg and 100 mg & 100 mg and 150 mg respectively GlaxoSmithKline NDA 18-644/S-022/S-024 & 20-358/S-018/S-024 10/2/02 10/2/02 Wellbutrin (bupropion hydrochloride) Immediate-Release & Sustained-Release Tablets, 75 mg and 100 mg & 100 mg and 150 mg respectively Glaxo SmithKline NDA 18-644/S-022/S-023 & 20-358/S-018/S-023 6/20/02 6/24/02 Wellbutrin SR (bupropion hydrochloride) Sustained-Release Tablets, 100 & 150 mg, GlaxoSmithKline NDA 20-358/S28 7/12/02 7/15/02 Wellbutrin SR (bupropion hydrochloride) Sustained-Release Tablets, Glaxo Wellcome NDA 20-358/S27 6/14/02 6/17/02 6/14/02 Wellbutrin SR (bupropion hydrochloride) Sustained-Release Tablets, 100 & 150 mg Glaxo Wellcome NDA 20-358/S25 2/13/02 Wellbutrin SR (bupropion hydrochloride) Sustained-Release Tablets, 100 & 150 mg Glaxo Wellcome NDA 20-358/S19 6/11/01 11/6/01 11/6/01 11/28/01 Wellbutrin XL (bupropion hydrochloride) Extended-Release Tablets, GlaxoSmithKline NDA 21-515 8/28/03 09/09/03 Wellbutrin (bupropion hydrochloride) Tablets GlaxoSmithKline NDA 18644/SCM-025 Zyban (bupropion hydrochloride) Sustained-Release Tablets, GlaxoSmithKline NDA 20-711/S13, S14, S16 & S18 2/14/03 2/25/03 2/25/03 Zyban (bupropion hydrochloride) extended-release tablets. GlaxoSmithKline NDA 20-711/S-015 2/21/02 2/21/02 Zyban (bupropion hydrochloride) Sustained-Release Tablets, GlaxoSmithKline NDA 20-711/S-012 BUPROPION HYDROCHLORIDE Tablet, Extended Release; 100MG WELLBUTRIN SR GLAXOSMITHKLINE 020358 BUPROPION HYDROCHLORIDE Tablet, Extended Release; 150MG WELLBUTRIN SR GLAXOSMITHKLINE 020711 BUPROPION HYDROCHLORIDE Tablet, Extended Release; 150MG ZYBAN GLAXOSMITHKLINE 020358 BUPROPION HYDROCHLORIDE Tablet, Extended Release; 200MG WELLBUTRIN SR GLAXOSMITHKLINE 020358 BUPROPION HYDROCHLORIDE Tablet, Extended Release; 50MG WELLBUTRIN SR GLAXOSMITHKLINE 021515 BUPROPION HYDROCHLORIDE Tablet, Extended Release; 150MG WELLBUTRIN XL SMITHKLINE BEECHAM 021515 BUPROPION HYDROCHLORIDE Tablet, Extended Release; 300MG WELLBUTRIN XL SMITHKLINE BEECHAM 075613 BUPROPION HYDROCHLORIDE Tablet; 100MG BUPROPION HCL Eon 075613 BUPROPION HYDROCHLORIDE Tablet; 75MG BUPROPION HCL Eon 075584 BUPROPION HYDROCHLORIDE Tablet; 100MG BUPROPION HCL Geneva TECH 075584 BUPROPION HYDROCHLORIDE Tablet; 75MG BUPROPION HCL Geneva TECH 018644 BUPROPION HYDROCHLORIDE Tablet; 100MG WELLBUTRIN GLAXOSMITHKLINE 018644 BUPROPION HYDROCHLORIDE Tablet; 75MG WELLBUTRIN GLAXOSMITHKLINE 075491 BUPROPION HYDROCHLORIDE Tablet; 100MG BUPROPION HCL Mylan 075491 BUPROPION HYDROCHLORIDE Tablet; 75MG BUPROPION HCL Mylan 075310 BUPROPION HYDROCHLORIDE Tablet; 100MG BUPROPION HCL Teva 075310 BUPROPION HYDROCHLORIDE Tablet; 75MG BUPROPION HCL Teva Bupropion Hydrochloride Extended-Release Tablets, Eon Labs Bupropion Hydrochloride Extended-Release Tablets, Impax Laboratories Bupropion Hydrochloride Extended-Release Tablets, Eon Labs Bupropion Hydrochloride Extended-Release Tablets, Impax Laboratories Wellbutrin SR (bupropion hydrochloride) Sustained-Release Tablets, GlaxoSmithKline Bupropion Hydrochloride Extended-release Tablets, Impax Laboratories Wellbutrin Immediate Release Tablets, GlaxoSmithKline Wellbutrin SR (bupropion hydrochloride) Sustained-Release Tablets, GlaxoSmithKline Wellbutrin XL (bupropion hydrochloride) Extended-Release Tablets, GlaxoSmithKline | Wellbutrin XL (bupropion hydrochloride) Extended-Release Tablets, GlaxoSmithKline, Labeling Revision | ZYBAN (bupropion hydrochloride), GlaxoSmithKline, Labeling Revision | Bupropion Hydrochloride Extended-Release Tablets, Impax Labs, Approval | Wellbutrin Immediate Release Tablets, GlaxoSmithKline, Labeling Revision | Wellbutrin SR (bupropion hydrochloride) Sustained-Release Tablets, GlaxoSmithKline, Labeling Revision | Wellbutrin XL (bupropion hydrochloride) Extended-Release Tablets, GlaxoSmithKline, Labeling Revision | Zyban (bupropion hydrochloride) Sustained-Release Tablets, GlaxoSmithKline, Labeling Revision | Bupropion Hydrochloride Extended-Release Tablets, Eon Labs, New Strength | Bupropion Hydrochloride Extended Release Tablets, Sandoz, Approval | Bupropion Hydrochloride Extended Release Tablets, Sandoz, Approval | Bupropion Hydrochloride Extended-Release Tablets, Anchen Pharma, Tentative Approval | Bupropion Hydrochloride Tablets, Apotex Inc., Approval | Wellbutrin Immediate Release Tablets, GlaxoSmithKline, Labeling Revision | Wellbutrin SR Sustained-Release Tablets, GlaxoSmithKline, Labeling Revision | Wellbutrin XL Extended-Release Tablets, GlaxoSmithKline, Labeling Revision | Zyban (bupropion hydrochloride) Sustained-Release Tablets, GlaxoSmithKline, Labeling Revision | Zyban (bupropion hydrochloride) Sustained-Release Tablets, GlaxoSmithKline, Labeling Revision | Wellbutrin XL (bupropion hydrochloride) Extended-Release Tablets, GlaxoSmithKline, New or Modified Indication | Wellbutrin Immediate Release Tablets GlaxoSmithKline, Labeling Revision | Wellbutrin SR (bupropion hydrochloride) Sustained-Release Tablets, GlaxoSmithKline, Labeling Revision | Wellbutrin XL (bupropion hydrochloride) Extended-Release Tablets, GlaxoSmithKline, Labeling Revision | Bupropion Extended-Release Tablets, Anchen Pharma, Approval | Wellbutrin (bupropion HCl) Tablets, GlaxoSmithKline, Labeling Revision | Wellbutrin SR (bupropion HCl) Sustained-Release Tablets, GlaxoSmithKline, Labeling Revision | Bupropion Hydrochloride Extended-release Tablets, Watson Labs, Tentative Approval Visit Betterchem's Drug Index for FDA's latest approval information.   Find other drugs… A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | USActives.com | Pharma Job Search | Pharma Company News © 2011 FindingHealthOnline™